Illness perception and clinical treatment experiences in patients with M. Maroteaux-Lamy (mucopolysaccharidosis type VI) and a Turkish migration background in Germany.
<h4>Introduction</h4>Mucopolysaccharidosis VI (MPS VI) is an inherited lysosomal storage disease caused by a mutation of the gene for arylsulfatase B (ASB). Of the thirty-one patients registered in Germany, almost fifty percent have a Turkish migration background. MPS VI is treated by en...
Guardado en:
Autores principales: | Hansjörg Dilger, Linn Leissner, Lenka Bosanska, Christina Lampe, Ursula Plöckinger |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a862121436bf460aa9552e4e48043b48 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome): defining and measuring functional impacts in pediatric patients
por: Beth Leiro, et al.
Publicado: (2021) -
A systematic review of new advances in the management of mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): focus on galsulfase
por: Regina P El Dib, et al.
Publicado: (2009) -
ROAD AND JOURNEY IN THE FERHAD AND ŞIRIN OF LAMI’I CELEBI
por: Giyasi BABAARSLAN
Publicado: (2021) -
À Pierre Lévêque, au savant et à l’ami
por: Antonio Gonzales
Publicado: (2003) -
DETERMINATION OF SOURCES OF TURKS WITH TURKISH PROBLEMS IN GERMANY
por: Bülent KIRMIZI
Publicado: (2019)